ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 4
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in KDSR Cause Recessive Progressive Symmetric Erythrokeratoderma.
|
28575652 |
2017 |
ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 4
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutations in KDSR Cause Recessive Progressive Symmetric Erythrokeratoderma.
|
28575652 |
2017 |
ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 4
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 4
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Lymphoma, Follicular
|
0.320 |
Biomarker
|
disease |
CTD_human |
Towards a systematic analysis of human short-chain dehydrogenases/reductases (SDR): Ligand identification and structure-activity relationships.
|
25526675 |
2015 |
Lymphoma, Follicular
|
0.320 |
AlteredExpression
|
disease |
LHGDN |
We investigated the expression of FVT1 in a variety of B-cell non-Hodgkin lymphomas and found that FVT1 is significantly underexpressed by germinal center-type diffuse large B-cell lymphoma (DLBCL) when compared with non-germinal center-type DLBCL, follicular lymphoma, and normal tonsil control samples.
|
19019774 |
2008 |
Lymphoma, Follicular
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
The proximity of FVT-1 to the BCL-2 locus suggests that in the t(14;18) currently observed in follicular lymphomas, both genes would participate in the tumoral process.
|
8417785 |
1993 |
Erythrokeratodermia variabilis
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
KDSR or 3-keto-dihydrosphingosine reductase is an essential enzyme for <i>de novo</i> sphingolipid synthesis, and pathogenic mutations in <i>KDSR</i> result in the severe skin disorder <i>erythrokeratodermia variabilis et progressiva-4</i> Four of the eight reported cases also had thrombocytopenia but the underlying mechanism has remained unexplored.
|
30467204 |
2019 |
Erythrokeratodermia variabilis
|
0.310 |
GermlineCausalMutation
|
disease |
ORPHANET |
Mutations in KDSR Cause Recessive Progressive Symmetric Erythrokeratoderma.
|
28575652 |
2017 |
Blood Platelet Disorders
|
0.300 |
Biomarker
|
group |
GENOMICS_ENGLAND |
Mutations in KDSR Cause Recessive Progressive Symmetric Erythrokeratoderma.
|
28575652 |
2017 |
Lymphoma, Large-Cell, Follicular
|
0.300 |
Biomarker
|
disease |
CTD_human |
Towards a systematic analysis of human short-chain dehydrogenases/reductases (SDR): Ligand identification and structure-activity relationships.
|
25526675 |
2015 |
Lymphoma, Mixed-Cell, Follicular
|
0.300 |
Biomarker
|
disease |
CTD_human |
Towards a systematic analysis of human short-chain dehydrogenases/reductases (SDR): Ligand identification and structure-activity relationships.
|
25526675 |
2015 |
Lymphoma, Small Cleaved-Cell, Follicular
|
0.300 |
Biomarker
|
disease |
CTD_human |
Towards a systematic analysis of human short-chain dehydrogenases/reductases (SDR): Ligand identification and structure-activity relationships.
|
25526675 |
2015 |
Lymphoma, Follicular, Grade 1
|
0.300 |
Biomarker
|
disease |
CTD_human |
Towards a systematic analysis of human short-chain dehydrogenases/reductases (SDR): Ligand identification and structure-activity relationships.
|
25526675 |
2015 |
Lymphoma, Follicular, Grade 3
|
0.300 |
Biomarker
|
disease |
CTD_human |
Towards a systematic analysis of human short-chain dehydrogenases/reductases (SDR): Ligand identification and structure-activity relationships.
|
25526675 |
2015 |
Lymphoma, Follicular, Grade 2
|
0.300 |
Biomarker
|
disease |
CTD_human |
Towards a systematic analysis of human short-chain dehydrogenases/reductases (SDR): Ligand identification and structure-activity relationships.
|
25526675 |
2015 |
Alopecia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Corneal Opacity
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Diabetes Mellitus
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Dwarfism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Exanthema
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Glaucoma
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Palmoplantar Keratosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Microcephaly
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Skin Neoplasms
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|